
    
      This is a prospective, randomized, double-blind (subject and physical therapist), sham needle
      injection controlled, single center, multi-site study.

      Subjects with primary osteoarthritis knee pain will be randomly assigned to a 6 ml
      intra-articular injection of Synvisc-One or sham needle injection.

      The post-treatment course of physical therapy will begin between Day 3 and Day 14 and will
      last up to 12 weeks in duration (PT ends at study Week 12). Subjects are encouraged to
      complete between 6 and 16 physical therapy visits within 10-12 weeks of physical therapy
      treatment as determined by the treating Physical Therapist.
    
  